Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02748408 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Medacta International SMS Post-Marketing Surveillance Study

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Site details revised at 1 of 4 sitesv7
  2. Re-verified, no change to tracked fieldsv6
  3. Study sites: 3 to 4 Secondary endpoints revised (7)v5 Show 1 more changeShow less
    • Secondary endpoints revised (7)

    See this version in full on ClinicalTrials.gov ↗

  4. Study sites: 2 to 3v4
  5. Primary and study completion dates: Jul 2028 to Jul 2032v3
  6. Study sites: 1 to 2v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a Post-Marketing Surveillance of SMS femoral stem prosthesis.
Trial Details
NCT Number NCT02748408
Lead Sponsor Medacta International SA
Conditions Arthrosis, Traumatic Arthritis, Rheumatoid Polyarthritis, Congenital Hip Dysplasia, Avascular Necrosis of the Femoral Head
Enrollment 550 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov